BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2007
View Archived Issues
New therapeutic agents for neurological disorders reported in recent patents
Read More
Novel therapeutic agents for cardiovascular disorders imparted in recent patents
Read More
New therapeutics for cancer covered in recent patent literature
Read More
Angptl4 validated as a drug target in cardiovascular disorders
Read More
PRT-054021 prevents venous thromboembolism after knee replacement
Read More
Tolevamer liquid fails to meet primary endpoint in CDAD trial
Read More
Roche and Alnylam form alliance in RNAi therapeutics
Read More
Bristol-Myers Squibb terminates MIV-170 license agreement with Medivir
Read More
Prolonged treatment with amylin mimetic peptide slows gastric emptying and improves glucose control
Read More
PTP1B inhibition improves insulin sensitivity via increases in adiponectin in obese monkeys
Read More
ProEthic files NDA for PRO-513 for migraine headaches
Read More
Silence Therapeutics and AstraZeneca to codevelop siRNA molecules
Read More
BHI-001: a novel Hsp90 inhibitor with improved therapeutic index
Read More
GW and Otsuka collaborate to research and develop cannabinoids
Read More
Clavis Pharma's phase II combination study of Elacyt approved
Read More
Positive results for transdermal delivery of hPTH (1-34) in phase I trials
Read More
Hsp32 validated as a therapeutic target in systemic mastocytosis
Read More
SPA agreement for pivotal study of oral Fodosine in cutaneous T-cell lymphoma
Read More
Japanese launch for Nesp
Read More
Positive preclinical results of new CRAC channel inhibitor in models of allergic inflammation
Read More